1. Home
  2. SOBR vs BBLG Comparison

SOBR vs BBLG Comparison

Compare SOBR & BBLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SOBR Safe Inc.

SOBR

SOBR Safe Inc.

HOLD

Current Price

$0.90

Market Cap

2.4M

ML Signal

HOLD

BBLG

Bone Biologics Corp

HOLD

Current Price

$1.46

Market Cap

2.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SOBR
BBLG
Founded
2004
2004
Country
United States
United States
Employees
N/A
2
Industry
Newspapers/Magazines
Industrial Specialties
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4M
2.6M
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
SOBR
BBLG
Price
$0.90
$1.46
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
191.0K
37.2K
Earning Date
04-10-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
103.55
N/A
EPS
N/A
N/A
Revenue
$437,421.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
105.62
N/A
52 Week Low
$0.48
$1.05
52 Week High
$5.27
$4.13

Technical Indicators

Market Signals
Indicator
SOBR
BBLG
Relative Strength Index (RSI) 43.78 64.18
Support Level $0.69 $1.24
Resistance Level $1.03 $1.88
Average True Range (ATR) 0.12 0.09
MACD -0.03 0.03
Stochastic Oscillator 31.30 75.76

Price Performance

Historical Comparison
SOBR
BBLG

About SOBR SOBR Safe Inc.

Sobr Safe Inc is a hardware and software company. The Company integrates proprietary software, SOBRsafeTM, with its patented touch-based personal alcohol awareness tracking products, SOBRcheckTM and SOBRsure, enabling non-invasive personal alcohol awareness tracking, biometric identity verification, and qualified, real-time cloud-based, informational alerts and reporting. It operates as a single segment designed to enable customers to purchase products directly through channel partners, sales agents or through its enterprise and consumer digital channels. Currently its principal markets are located in North America.

About BBLG Bone Biologics Corp

Bone Biologics Corp a medical device company that is currently focused on bone regeneration in spinal fusion using the recombinant human protein known as NELL-1. NELL-1 in combination with DBM, demineralized bone matrix, is an osteopromotive recombinant protein that provides target specific control over bone regeneration. It is a clinical-stage entity. The production and marketing of its products and ongoing research and development activities are subject to extensive regulation by numerous governmental authorities in the United States.

Share on Social Networks: